FDAnews
www.fdanews.com/articles/125193-transgene-sells-option-on-cancer-vaccine-to-novartis

Transgene Sells Option on Cancer Vaccine to Novartis

March 10, 2010
Transgene SA, the French biotechnology company backed by the billionaire Merieux family, sold Novartis AG an option on rights to the experimental TG4010 cancer vaccine in a deal that may fetch as much as $960 million.
BusinessWeek